Background
Drug-associated cues can elicit stress-like responses in addicted individuals, indicating thatcue- and stress-induceddrug relapse may share some neural mechanisms.It is unknown whetherα2 adrenergic receptor agonists, which are known toattenuate stress-induced reinstatement of drug-seeking in rats,also reduce cue-induced reinstatement.
Methods
Rats were tested for reinstatement of drug-seekingfollowing cocaine self-administration and extinction. We first evaluated the effects ofclonidine, an agonist at α2 and imidazoline-1 (I1) receptors, on relapse to cocaine-seeking. To explore possible mechanisms of clonidine’s effects, we then tested more specific α2 or I1 agonists, post-synaptic adrenergic receptor (α1 and β) antagonists, andcorticotropin-releasing factor receptor-1 (CRF R1) antagonists.
Results
We found that clonidine,andthe more selective α2 agonists UK-14,304 and guanfacine, decreased cue-induced reinstatement of cocaine-seeking.The specific I1 receptor agonist moxonidine reduced cue-induced as well as cocaine-induced reinstatement.Clonidine or moxonidine effects on cue-induced reinstatementwere reversed by the selective α2 receptor antagonist RS-79948, indicatinga role for α2 receptors.Prazosin and propranolol, antagonists at the α1and β receptor, respectively, reducedcue-induced reinstatement only when administered in combination. Finally, the CRF R1 antagonist CP-154,526reduced cue-induced reinstatement, as previouslyobservedfor stress-induced reinstatement, indicating possible overlap between stress and cue mechanisms.
Conclusions
These results indicate that α2 and I1 receptor agonists are novel therapeutic options for prevention of cue-induced cocaine relapse. Given that α2 receptor stimulation is associated with sedation in humans, the I1agonist moxonidineseems to have substantial potential for treating addictive disorders.